Adult acute respiratory distress syndrome
MONDO:0100130A very severe form of acute pulmonary failure secondary to capillary permeability impairment. The symptoms include dyspnea, hypotension and multivisceral failure. The disease is characterized by bilateral pulmonary infiltrates and severe hypoxemia due to increased alveolar-capillary permeability. The severity depends on the degree of alveolar epithelial injury, with a mortality rate of 30-50%.
Also known as: adult ARDS, adult acute respiratory distress syndrome, adult respiratory distress syndrome, adult respiratory distress syndrome, ARDS, respiratory distress syndrome, adult, ARDS
264 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a simple vest help COVID-19 patients breathe easier?
Disease control ENROLLING_BY_INVITATIONThis study tests a non-invasive pneumatic vest designed to apply pressure to the chest wall in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 who are on mechanical ventilators. The goal is to see if the vest can improve oxygen levels in the blood. Up …
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
One-Size-Fits-All oxygen may be outdated: new trial tests personalized targets
Disease control ENROLLING_BY_INVITATIONThis study is testing whether giving each patient on a ventilator a personalized oxygen target (based on their unique health data) leads to better outcomes than standard care. Researchers will compare death rates and time spent on the ventilator between the two groups. The trial …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Promising COVID-19 treatment trial pulled before it began
Disease control TerminatedThis study was designed to test whether an inhaled drug called ZYESAMI could help people with severe COVID-19 avoid getting worse and needing a ventilator. It was a Phase 3 trial, meaning it was in the final stage of testing. However, the study was withdrawn before any participan…
Phase: PHASE3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Promising pneumonia therapy trial pulled before it began
Disease control TerminatedThis study was designed to test whether adding an experimental drug and special immune cells to standard care could help critically ill adults with severe pneumonia, especially those with sepsis or lung failure. The trial was withdrawn before enrolling any participants, so no res…
Phase: PHASE3 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Immune boosting study for severe pneumonia pulled before start
Disease control TerminatedThis study was designed to see if adding two immune treatments (NAI and iNKT cells) to standard care could help critically ill adults with severe pneumonia, sepsis, or lung failure recover. It planned to enroll ICU patients and follow them for 90 days. However, the study was with…
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New care pathway aims to save lives of ICU patients with breathing failure
Disease control OngoingThis study looks at whether a step-by-step care plan (called TheraPPP) helps patients with severe breathing failure (ARDS) survive and spend less time on a ventilator. The plan includes proven treatments like protective ventilation, paralysis, and prone positioning. About 20,000 …
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Major trial seeks to end debate on ventilator strategies for kids
Disease control OngoingThis study compares two breathing support strategies—prone positioning and high-frequency ventilation—against standard care in 600 children with severe acute respiratory distress syndrome. The goal is to see which approach helps children spend more days off a ventilator within 28…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising ARDS drug trial pulled before it even started
Disease control TerminatedThis study was designed to test whether IC14, a drug that blocks a key inflammatory signal, could help people with acute respiratory distress syndrome (ARDS). The plan was to give IC14 or a placebo to about 100 ICU patients and see if it reduced time on a ventilator. However, the…
Phase: PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to save tiny lungs
Disease control OngoingThis Phase 3 trial tests whether adding budesonide (an anti-inflammatory) to standard surfactant treatment helps extremely preterm babies avoid chronic lung disease or death. About 642 infants born before 29 weeks or weighing under 1000 grams will receive either the combo or surf…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New trial aims to slash COVID-19 deaths and ventilator use
Disease control OngoingThis study tests several experimental treatments at once in critically ill COVID-19 patients who need high-flow oxygen or a ventilator. The goal is to quickly find which treatments can reduce deaths and shorten the time patients need breathing support. About 1,500 adults in the h…
Phase: PHASE2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Thyroid hormone sprayed into lungs to fight COVID ARDS? trial pulled before start
Disease control TerminatedThis study planned to test whether putting a thyroid hormone (T3) directly into the lungs could help people with severe COVID-19 who need a breathing machine. The goal was to reduce fluid in the lungs and shorten time on a ventilator. However, the trial was withdrawn before any p…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Stem cell therapy for COVID-19 lung damage trial pulled before it began
Disease control TerminatedThis early-stage study aimed to test whether infusing donor stem cells could help people recover from acute respiratory distress syndrome (ARDS) caused by COVID-19. The trial was withdrawn before enrolling any participants, so no results are available. The approach was based on e…
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stem cell study for COVID lung failure pulled before it began
Disease control TerminatedThis study planned to test a new stem cell product (BX-U001) in people with severe COVID-19 pneumonia and moderate to severe lung failure (ARDS). The goal was to check safety and find the best dose. However, the study was withdrawn before enrolling any participants, so no results…
Phase: PHASE1, PHASE2 • Sponsor: Baylx Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New antibody aimed at ARDS shows promise in early trial
Disease control OngoingThis study tests a single dose of an antibody called ALT-100 in people with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. The trial involves 15 hospitalized adults and compares the drug to a placebo. The main goal is to check sa…
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Robot trainer aims to keep seniors on their feet during hospital stays
Disease control OngoingThis study tests whether robot-assisted leg exercises can prevent older patients from losing strength and independence during a hospital stay. 488 patients aged 65 and older will either receive robot-guided training or standard care. The goal is to see if the robot helps them wal…
Phase: NA • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:52 UTC
-
Could umbilical cord stem cells save lungs in ARDS?
Disease control OngoingThis trial tests whether a single infusion of stem cells from donated umbilical cords can help people with acute respiratory distress syndrome (ARDS), a severe lung condition often seen in intensive care. The study first finds a safe dose, then randomly gives either stem cells or…
Phase: PHASE1, PHASE2 • Sponsor: Belfast Health and Social Care Trust • Aim: Disease control
Last updated Jun 26, 2026 14:28 UTC
-
New inflatable cushion could revolutionize ICU patient repositioning
Symptom relief OngoingThis trial tests a new inflatable cushion called the BathMat, designed to help reposition patients lying on their stomachs (proned) in the ICU. Proning helps patients with severe breathing problems get more oxygen, but repositioning them every few hours currently requires at leas…
Phase: NA • Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a thyroid hormone boost oxygen in severe lung failure?
Symptom relief OngoingThis study tests whether giving a thyroid hormone (T3) directly into the lungs can safely improve oxygen levels in adults with acute respiratory distress syndrome (ARDS), a severe lung condition. About 68 critically ill patients on ventilators will either receive the hormone or s…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Brain scans may predict recovery from ICU delirium in lung failure patients
Knowledge-focused TerminatedThis study investigates cognitive problems in intensive care patients with acute respiratory distress syndrome (ARDS) who develop delirium (sudden confusion). Researchers use a non-invasive EEG cap and auditory tests to measure brain activity at the bedside. The goal is to identi…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
ECMO Patients' hidden infection risk under the microscope
Knowledge-focused OngoingThis study follows 200 adults on ECMO (a heart-lung machine) for severe breathing problems. Researchers track how many get hospital-acquired infections and measure antibiotic levels in their blood and lungs. The goal is to learn more about infections and drug dosing in these crit…
Sponsor: Policlinico Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Ultrasound peek at diaphragm could guide breathing support
Knowledge-focused OngoingThis study observes how the diaphragm works in 100 adults with acute respiratory failure who need non-invasive breathing support or high-flow oxygen. Researchers use ultrasound to measure diaphragm movement and thickness at different support levels. The goal is to understand how …
Sponsor: Foro Internacional en Cuidado Crítico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Could a skin blister test lead to a treatment for 'Drowning from the Inside'?
Knowledge-focused OngoingThis study tests whether a drug called racecadotril can reduce fluid leakage in skin blisters, as a model for what happens in the lungs during Acute Respiratory Distress Syndrome (ARDS). ARDS is a severe lung injury with no effective drug treatments, where patients' lungs fill wi…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Baby breathing machine under the microscope: new study watches how it works
Knowledge-focused OngoingThis study watches how a high-frequency ventilator (Servo-n HFOV) works in real hospital use for babies with severe breathing failure. About 75 infants will be observed to see if the machine safely helps them get enough oxygen and remove carbon dioxide. The goal is to gather info…
Sponsor: Maquet Critical Care AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New monitoring technique could personalize breathing support for ICU patients
Knowledge-focused OngoingThis study follows 120 adults with moderate-to-severe ARDS who are on a breathing machine. Researchers use a non-invasive belt (electrical impedance tomography) to track how air and blood flow are distributed in the lungs over time. The goal is to see if different lung function p…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Could bile acids cause baby lung issues? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at babies born to mothers with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and high bile acid levels. Researchers want to see if these bile acids can lead to breathing problems in newborns. They will compare 120 babies—some …
Sponsor: Carol Davila University of Medicine and Pharmacy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
AI vs. doctors: can a computer make the right call for sepsis?
Knowledge-focused ENROLLING_BY_INVITATIONThis study asks 350 critical care doctors and advanced practice providers to review fictional patient cases of sepsis and ARDS. Each case includes treatment recommendations that were either made by a real clinician or generated by an artificial intelligence system. The participan…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
COVID lung damage: who gets scarred?
Knowledge-focused OngoingThis study follows 200 ICU patients with severe COVID-19 to see how often they develop lung scarring (pulmonary fibrosis). Researchers will use blood tests and CT scans to find early signs of scarring and identify risk factors. The goal is to understand how scarring affects recov…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
New breath test could replace painful lung scopes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if a simple, non-invasive breathing test can accurately measure the acidity (pH) in the airways, which is often abnormal in lung diseases. Researchers will compare results from this breath test with standard methods in 150 healthy volunteers and people with…
Phase: PHASE2 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
How ready are medics for a chemical attack? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how well medical teams follow safety guidelines when treating people hurt in a chemical, biological, or nuclear attack. Researchers will track 1,000 patients to see if care is given without delay and if contamination is controlled during rescue. The goal is to…
Sponsor: St. Justine's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Brain scans reveal hidden links between body diseases and metabolism
Knowledge-focused OngoingThis study watches 200 people with lung, gut, or hormone diseases over time using special brain scans (PET). It aims to see how these diseases change brain activity and whether those changes can predict tumor return, spread, or survival. No new treatment is tested—just observatio…
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC